Df Dent & CO Inc Repligen Corp Transaction History

Df Dent & CO Inc

$6.89 Billion
Q1 2025

A detailed history of Df Dent & CO Inc transactions in Repligen Corp stock. As of the latest transaction made, Df Dent & CO Inc holds 574,676 shares of RGEN stock, worth $73.3 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

574,676

Previous 563,280 2.02%

Holding current value

$73.3 Million

Previous $81.1 Million 9.81%

% of portfolio

1.06%

Previous 1.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$127.24 - $174.24 $1.45 Million - $1.99 Million	11,396 Added 2.02%	574,676 $73.1 Million
Q4 2024 Feb 12, 2025	SELL	$123.41 - $160.92 $3.34 Million - $4.35 Million	-27,041 Reduced 4.58%	563,280 $81.1 Million
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $16.7 Million - $23.4 Million	139,615 Added 30.98%	590,321 $87.9 Million
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $1.3 Million - $1.98 Million	10,828 Added 2.46%	450,706 $56.8 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $7.94 Million - $9.69 Million	-46,475 Reduced 9.56%	439,878 $80.9 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $11.6 Million - $18.8 Million	101,277 Added 26.3%	486,353 $87.4 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $41.1 Million - $53.6 Million	297,064 Added 337.53%	385,076 $54.5 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $1.1 Million - $1.41 Million	7,103 Added 8.78%	88,012 $14.8 Million
Q4 2022 Feb 15, 2023	SELL	$162.42 - $220.56 $457,049 - $620,655	-2,814 Reduced 3.36%	80,909 $13.7 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $2.14 Million - $3.42 Million	-13,356 Reduced 13.76%	83,723 $15.7 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $1.08 Million - $1.45 Million	7,711 Added 8.63%	97,079 $15.8 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $4.52 Million - $7.24 Million	28,059 Added 45.77%	89,368 $16.8 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $121,814 - $149,799	-492 Reduced 0.8%	61,309 $16.2 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $793,687 - $1.32 Million	4,075 Added 7.06%	61,801 $17.9 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $614,216 - $818,177	3,703 Added 6.85%	57,726 $11.5 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $731,941 - $918,163	4,058 Added 8.12%	54,023 $10.5 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $644,592 - $899,199	4,353 Added 9.54%	49,965 $9.58 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $160,733 - $207,650	1,312 Added 2.96%	45,612 $6.73 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $1.55 Million - $2.31 Million	16,452 Added 59.08%	44,300 $5.48 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $2.37 Million - $3.04 Million	27,848 New	27,848 $2.69 Million

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.07B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.

Account